Discover

OBIO
Orchestra BioMed Holdings, Inc.
3.69
1 x 3.21
1 x 5.61
bid
ask
+
0.00
0.00%
04:00 PM
Ytd-11.08%
1y16.77%
day range
2.20
52 week range
5.42
OpenPrev Close3.69LowHighMkt Cap220.96M
Vol0.00Avg Vol335.41KEPS-0.97P/E-3.80Forward P/E-2.66
Beta0.49Short Ratio12.51Inst. Own54.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg3.98200-d Avg4.121yr Est15.60

OBIO News

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

B. Riley Securities analyst Kyle Bauser maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy

benzinga.com
HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Bu

benzinga.com
Barclays Maintains Overweight on Orchestra BioMed Hldgs, Raises Price Target to $13

Barclays analyst Matt Miksic maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Overweight and

benzinga.com
Orchestra BioMed Hldgs Q1 EPS $(0.33) Beats $(0.41) Estimate, Sales $110.000K Miss $190.750K Estimat

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.33) per share which beat the a

benzinga.com
Orchestra BioMed Plans To Complete Enrollment In Its BACKBEAT Study Of Atrioventricular Interval Mod

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"),

benzinga.com
Orchestra BioMed Receives $15M Payment From Ligand Pharma Under Previously Disclosed Revenue Partici

$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, b

benzinga.com
Orchestra BioMed Receives $20M Investment From Medtronic Under Previously Announced Strategic Financ

Payment fulfills previously disclosed funding commitment of $20 million and supports planned complet

benzinga.com
Orchestra BioMed Announces Second FDA Breakthrough Device Designation For AVIM Therapy Specific To P

Together, the two BDDs for AVIM Therapy cover indications that encompass both the broader population

benzinga.com
Orchestra BioMed Hldgs Q4 EPS $0.26 Beats $(0.39) Estimate, Sales $30.917M Beat $878.600K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly earnings of $0.26 per share which beat the a

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session